AU2019903860A0 - Concealment of hypomineralised lesions (2) - Google Patents

Concealment of hypomineralised lesions (2)

Info

Publication number
AU2019903860A0
AU2019903860A0 AU2019903860A AU2019903860A AU2019903860A0 AU 2019903860 A0 AU2019903860 A0 AU 2019903860A0 AU 2019903860 A AU2019903860 A AU 2019903860A AU 2019903860 A AU2019903860 A AU 2019903860A AU 2019903860 A0 AU2019903860 A0 AU 2019903860A0
Authority
AU
Australia
Prior art keywords
hypomineralised
concealment
lesions
hypomineralised lesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019903860A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2019903860A0 publication Critical patent/AU2019903860A0/en
Priority to CA3133098A priority Critical patent/CA3133098A1/en
Priority to SG11202109876W priority patent/SG11202109876WA/en
Priority to BR112021018034A priority patent/BR112021018034A2/en
Priority to PCT/AU2020/050239 priority patent/WO2020181335A1/en
Priority to KR1020217032306A priority patent/KR20210139320A/en
Priority to CN202080034171.XA priority patent/CN113811278A/en
Priority to EP20770138.4A priority patent/EP3937881A4/en
Priority to MX2021011094A priority patent/MX2021011094A/en
Priority to AU2020234723A priority patent/AU2020234723A1/en
Priority to EA202192427A priority patent/EA202192427A1/en
Priority to US17/438,299 priority patent/US20220183810A1/en
Priority to JP2021555285A priority patent/JP2022524856A/en
Abandoned legal-status Critical Current

Links

AU2019903860A 2019-03-13 2019-10-14 Concealment of hypomineralised lesions (2) Abandoned AU2019903860A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP2021555285A JP2022524856A (en) 2019-03-13 2020-03-13 Concealment of hypocalcified lesions
KR1020217032306A KR20210139320A (en) 2019-03-13 2020-03-13 Concealment of hypomineralized lesions
SG11202109876W SG11202109876WA (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
BR112021018034A BR112021018034A2 (en) 2019-03-13 2020-03-13 Concealment of hypomineralized lesions
PCT/AU2020/050239 WO2020181335A1 (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
CA3133098A CA3133098A1 (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
CN202080034171.XA CN113811278A (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
EP20770138.4A EP3937881A4 (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
MX2021011094A MX2021011094A (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions.
AU2020234723A AU2020234723A1 (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions
EA202192427A EA202192427A1 (en) 2019-10-14 2020-03-13 REDUCED VISIBILITY OF HYPOMINERALIZED DAMAGES
US17/438,299 US20220183810A1 (en) 2019-03-13 2020-03-13 Concealment of hypomineralised lesions

Publications (1)

Publication Number Publication Date
AU2019903860A0 true AU2019903860A0 (en) 2019-10-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3937881A4 (en) Concealment of hypomineralised lesions
EP3969111A4 (en) Inhalable formulations for kinase inhibition
EP3935037A4 (en) Use of 8,9-dihydrocannabidiol compounds
EP3974441A4 (en) Novel peptide compound or pharmaceutically acceptable salt thereof
EP3765619A4 (en) Inhibitors of micro-rna 22
EP4014986A4 (en) Application of polypeptide or derivative thereof
EP4070183A4 (en) Behavior-based comparison of software
EP4083034A4 (en) Compound having khk inhibitory effect
EP4058454A4 (en) Inhibitor of apoptosis (iap) protein antagonists
EP3917910A4 (en) Therapeutic compounds and compositions
EP3782533A4 (en) Endoscope reprocessor
EP3797676A4 (en) Endoscope reprocessor
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3810118A4 (en) Formulations of tegavivint and related compounds
AU2019903860A0 (en) Concealment of hypomineralised lesions (2)
TWI799792B (en) Endoscopes
EP3935074A4 (en) Isthmin 1 for treatment of lung inflammation
EP4062820A4 (en) Endoscope
EP4130844A4 (en) Endoscope
EP4024114A4 (en) Endoscope
AU2019900833A0 (en) Concealment of hypomineralised lesions
AU2019900626A0 (en) Concealment of hypomineralised lesions
EP4031130A4 (en) Compositions for the treatment of solid tumors
EP4029050A4 (en) Etching composition
EP3934632A4 (en) Esketamine for the treatment of depression